Characteristics of established and proposed sporadic creutzfeldt-jakob disease variants

Archives of Neurology

Volumn 66, Issue 2, 2009, Pages 208-215

  Appleby, Brian S ^a,d   Appleby, Kristin K ^b   Crain, Barbara J ^a   Onyike, Chiadi U ^a   Wallin, Mitchell T ^b,c   Rabins, Peter V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE;

ADULT; AGED; ARTICLE; BASAL GANGLION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; ELECTROENCEPHALOGRAPHY; FEMALE; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME;

14-3-3 PROTEINS; AGE OF ONSET; AGED; BASAL GANGLIA; BIOLOGICAL MARKERS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 60549089053     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2008.533     Document Type: Article

References (24)

1. World Health Organization. WHO Manual for Surveillance of Human Transmissible Spongiform Encephalopathies Including Variant Creutzfeldt-Jakob Disease. Geneva, Switzerland: World Health Organization: 2003.
2. Heidenhain A. Klinische und anatomische Untersuchungen uber eine eigenar-tige organische Erkrankung des Zentralnervensystems im praesenium. Archpsy-chiatr Nervenkr Z Gesamte Neurol psychiatr. 1929;118:49-114.
3. Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, et al. The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol. 1999;56(1):55-61.
4. Brownell B, Oppenheimer DR. An ataxic form of subacute presenile polioen-cephalopathy (Creutzfeldt-Jakob disease). J Neurol Neurosurg psychiatry. 1965;28:350-361.
5. Appleby BS, Appleby KK, Rabins pV. Does the presentation of Creutzfeldt-Jakob disease vary by age or presumed etiology? a meta-analysis of the past 10 years. J Neuropsychiatry Clin Neurosci. 2007;19(4):428-435.
6. Wall CA, Rummans TA, Aksamit AJ, Krahn LE, pankratz VS. psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. J Neuropsychiatry Clin Neurosci. 2005;17(4):489-495.
7. World Health Organization. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. Geneva, Switzerland: World Health Organization; February 9-11, 1998.
8. Geschwind MD, Josephs KA, parisi JE, Keegan BM. A 54-year-old man with slowness of movement and confusion. Neurology. 2007;69(19):1881-1887.
9. Appleby B, Appleby KK, Onyike C, Wallin M. Initial diagnosis predicts survival time in human prion disease. Abstract presented at: prion 2008 Meeting; October 8-10, 2008; Madrid, Spain.
10. Appleby BS, Appleby KK, Rabins pV. Cognitive and affective presentations of sporadic Creutzfeldt-Jakob disease: development of neuropsychiatric variants. J Neuropsychiatry Clin Neurosci. 2008;20:232-234. In: Abstracts presented at the 19th Annual Meeting of the American Neuropsychiatric Association; March 1-4,2008; Savannah, GA. Abstract p32.
11. Folstein MF, Folstein SE, McHugh pR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J psychiatr Res. 1975;12(3):189-198.
12. Gambetti P, Dong Z, Yuan J, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol. 2008;63(6):697-708.
13. parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecularand phenotypic analysis of 300 subjects. Ann Neurol. 1999;46(2):224-233.
14. Aralasmak A, Crain BJ, Zou W, Yousem DM. A prion disease-possible Gerstmann-Straussler-Scheinker disease: a case report. J Comput Assist Tomogr. 2006;30(1):135-139.
15. Monari L, Chen SG, Brown P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. proc Natl Acad Sci U S A. 1994;91(7):2839-2842.
16. Kong Q. Inherited prion diseases. In: prusiner SB, ed. prion Biology and Diseases. Cold Spring Harbor, NY: CSHL press; 2004:673-775.
17. Josephs KA, Tsuboi Y, Dickson DW. Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy. Eur J Neurol. 2004;11(5):343-346.
18. Stone J, ZeidlerM, Sharpe M. Misdiagnosis of conversion disorder. Am J psychiatry. 2003;160(2):391-392.
19. du plessis DG, LarnerAJ. phenotypic similarities causing clinical misdiagnosis of pathologically-confirmed sporadic Creutzfeldt-Jakob disease as dementia with Lewy bodies. Clin Neurol Neurosurg. 2008;110(2):194-197.
20. Wieser HG, Schwarz U, Blattler T, et al. Serial EEG findings in sporadic and iatrogenic Creutzfeldt-Jakob disease. Clin Neurophysiol. 2004;115(11):2467-2478.
21. Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003;60(6):813-816.
22. parchi P, Castellani R, Capellari S, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 1996;39(6):767-778.
23. Notari S, Capellari S, Langeveld J, et al. A refined method for molecular typing reveals that co-occurrence of PrPSc types in Creutzfeldt-Jakob disease is not the rule. Lab Invest. 2007;87(11):1103-1112.
24. Pocchiari M, Puopolo M, Croes EA, et al. predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004;127(pt 10):2348-2359.